Journal of Pharmacy And Bioallied Sciences
Journal of Pharmacy And Bioallied Sciences Login  | Users Online: 1715  Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size 
    Home | About us | Editorial board | Search | Ahead of print | Current Issue | Past Issues | Instructions | Online submission


This article has been cited by
1Effects of Moxonidine Administration on Serum Neuropeptide Y Levels in Hypertensive Individuals: A Prospective Observational Study
Eleni Karlafti,Triantafyllos Didangelos,Emmanouil Benioudakis,Evangelia Kotzakioulafi,Georgia Kaiafa,Vasileios Kotsis,Antonios Ziakas,Michail Doumas,Antonios Goulas,Christos Savopoulos
Endocrines.2022;3(1)43
[DOI]
2Effective strategies for prevention of cardiovascular complications in elderly patients with arterial hypertension and obesity (clinical example)
A. P. Pereverzev,O. D. Ostroumova,E. V. Mironova
Medical alphabet.2020;3(21)10
[DOI]
3Investigation of the vasorelaxant effects of moxonidine and its relaxation mechanism on the human radial artery when used as a coronary bypass graft
Bulent Sarac,Ozge Korkmaz,Ahmet Altun,Ihsan Bagcivan,Sabahattin Göksel,Sahin Yildirim,Ocal Berkan
Interactive CardioVascular and Thoracic Surgery.2015;21(3)342
[DOI]
4The Influence of Hypertensive Therapies on Circulating Factors: Clinical Implications for SCFAs, FGF21, TNFSF14 and TNF-a
Aaron L. Magno,Lakshini Y. Herat,Márcio G. Kiuchi,Markus P. Schlaich,Natalie C. Ward,Vance B. Matthews
Journal of Clinical Medicine.2020;9(9)2764
[DOI]
5Non-fixed combination perindopril+moxonidine for blood pressure control in hypertensive patients with metabolic syndrome
S.V. Nedogoda,E.V. Chumachek,A.A. Ledyaeva,V.V. Tsoma,D.S. Vlasov,O.I. Bychkova
Kardiologiya i serdechno-sosudistaya khirurgiya.2021;14(2)208
[DOI]
6Cardiovascular Effects Mediated by Imidazoline Drugs: An Update
Luis Cobos-Puc,Hilda Aguayo-Morales
Cardiovascular & Hematological Disorders-Drug Targets.2019;19(2)95
[DOI]
7DFT, molecular docking and experimental FT-IR, FT-Raman, NMR inquisitions on “4-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-6-methoxy-2-methylpyrimidin-5-amine”: Alpha-2-imidazoline receptor agonist antihypertensive agent
S. Aayisha,T.S. Renuga Devi,S. Janani,S. Muthu,M. Raja,S. Sevvanthi
Journal of Molecular Structure.2019;1186(2)468
[DOI]
8Optimization of Pharmacotherapy Within the Framework of a Patient-oriented Approach in the Treatment of Hypertension in Multimorbidity Patients (Clinical Case and Literature Review)
O. D. Ostroumova,I. A. Alyautdinova,S. N. Litvinova,A. V. Arablinskij,A. A. Kirichenko
Rational Pharmacotherapy in Cardiology.2021;17(1)124
[DOI]
  Feedback 
  Subscribe 
  Advertise 

Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal